SG11201405163RA - Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor - Google Patents
Methods for treating or preventing influenza virus infection by administering a serine protease inhibitorInfo
- Publication number
- SG11201405163RA SG11201405163RA SG11201405163RA SG11201405163RA SG11201405163RA SG 11201405163R A SG11201405163R A SG 11201405163RA SG 11201405163R A SG11201405163R A SG 11201405163RA SG 11201405163R A SG11201405163R A SG 11201405163RA SG 11201405163R A SG11201405163R A SG 11201405163RA
- Authority
- SG
- Singapore
- Prior art keywords
- administering
- treating
- methods
- influenza virus
- protease inhibitor
- Prior art date
Links
- 229940122055 Serine protease inhibitor Drugs 0.000 title 1
- 101710102218 Serine protease inhibitor Proteins 0.000 title 1
- 239000003001 serine protease inhibitor Substances 0.000 title 1
- 241000712461 unidentified influenza virus Species 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261624519P | 2012-04-16 | 2012-04-16 | |
| US201361759469P | 2013-02-01 | 2013-02-01 | |
| PCT/US2013/036522 WO2013158516A1 (en) | 2012-04-16 | 2013-04-15 | Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201405163RA true SG11201405163RA (en) | 2014-09-26 |
Family
ID=48184523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201405163RA SG11201405163RA (en) | 2012-04-16 | 2013-04-15 | Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9498529B2 (en) |
| EP (2) | EP3536342A1 (en) |
| JP (2) | JP6446355B2 (en) |
| KR (1) | KR20150008383A (en) |
| CN (1) | CN104244978A (en) |
| AU (2) | AU2013249577A1 (en) |
| BR (1) | BR112014025339A8 (en) |
| CA (2) | CA3219083A1 (en) |
| HK (1) | HK1202817A1 (en) |
| MX (1) | MX2014012285A (en) |
| NZ (1) | NZ631105A (en) |
| SG (1) | SG11201405163RA (en) |
| WO (1) | WO2013158516A1 (en) |
| ZA (1) | ZA201406194B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109068621B (en) | 2016-02-29 | 2021-07-20 | 再生元制药公司 | Rodents with a humanized TMPRSS gene |
| KR101693243B1 (en) * | 2016-06-15 | 2017-01-05 | 재단법인 한국파스퇴르연구소 | Novel human gene crucial for the replication of influenza virus and use thereof |
| PL3638698T3 (en) * | 2018-01-26 | 2021-09-06 | Regeneron Pharmaceuticals, Inc. | Anti-tmprss2 antibodies and antigen-binding fragments |
| JP2023513124A (en) | 2020-02-10 | 2023-03-30 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Anti-TMPRSS2 Antibodies and Antigen-Binding Fragments |
| WO2021190980A1 (en) | 2020-03-22 | 2021-09-30 | Quadrucept Bio Limited | Multimers for viral strain evolution |
| WO2021195119A1 (en) * | 2020-03-24 | 2021-09-30 | Corcept Therapeutics Incorporated | Methods of reducing the risk of, severity of, and treating coronavirus infections |
| EP3964207A1 (en) | 2020-09-02 | 2022-03-09 | Christian-Albrechts-Universität zu Kiel | Antiviral pharmaceutical composition for topical administration |
| WO2022184659A1 (en) | 2021-03-01 | 2022-09-09 | Quadrucept Bio Limited | Antibody domains & multimers |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4839999A (en) * | 1998-06-29 | 2000-01-17 | Myriad Genetics, Inc. | Tmprss2 is a tumor suppressor |
| WO2004097358A2 (en) | 2003-05-02 | 2004-11-11 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2) |
| EP1846452B1 (en) * | 2005-01-07 | 2014-08-06 | Lexicon Pharmaceuticals, Inc. | Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 ) |
| WO2007089903A2 (en) | 2006-02-01 | 2007-08-09 | Brigham Young University | Cationic steroid microbial compositions for treating or preventing influenza infections |
| JP2008247864A (en) * | 2007-03-30 | 2008-10-16 | Univ Of Tokushima | Mosaic serine protease, MSP and its uses |
| JP2008308438A (en) * | 2007-06-14 | 2008-12-25 | Mitsubishi Tanabe Pharma Corp | New influenza therapeutic agent and/or prophylactic |
| EP2445963B1 (en) | 2009-06-22 | 2013-10-30 | Borealis AG | Automotive interior article with reduced smell |
| WO2013123254A1 (en) * | 2012-02-15 | 2013-08-22 | Cydex Pharmaceuticals, Inc. | Manufacturing process for cyclodextrin derivatives |
-
2013
- 2013-04-15 JP JP2015507076A patent/JP6446355B2/en active Active
- 2013-04-15 CN CN201380020133.9A patent/CN104244978A/en active Pending
- 2013-04-15 MX MX2014012285A patent/MX2014012285A/en active IP Right Grant
- 2013-04-15 NZ NZ631105A patent/NZ631105A/en unknown
- 2013-04-15 HK HK15103529.7A patent/HK1202817A1/en unknown
- 2013-04-15 CA CA3219083A patent/CA3219083A1/en active Pending
- 2013-04-15 BR BR112014025339A patent/BR112014025339A8/en not_active Application Discontinuation
- 2013-04-15 EP EP19155349.4A patent/EP3536342A1/en not_active Withdrawn
- 2013-04-15 SG SG11201405163RA patent/SG11201405163RA/en unknown
- 2013-04-15 AU AU2013249577A patent/AU2013249577A1/en not_active Abandoned
- 2013-04-15 WO PCT/US2013/036522 patent/WO2013158516A1/en active Application Filing
- 2013-04-15 KR KR1020147028956A patent/KR20150008383A/en not_active Ceased
- 2013-04-15 CA CA2869010A patent/CA2869010A1/en not_active Withdrawn
- 2013-04-15 EP EP13718744.9A patent/EP2838558A1/en not_active Ceased
- 2013-04-15 US US13/862,497 patent/US9498529B2/en active Active
-
2014
- 2014-08-22 ZA ZA2014/06194A patent/ZA201406194B/en unknown
-
2017
- 2017-10-20 JP JP2017203146A patent/JP2018048169A/en not_active Withdrawn
-
2018
- 2018-01-12 AU AU2018200265A patent/AU2018200265B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112014025339A8 (en) | 2018-01-16 |
| US20130273070A1 (en) | 2013-10-17 |
| US9498529B2 (en) | 2016-11-22 |
| CA3219083A1 (en) | 2013-10-24 |
| EP2838558A1 (en) | 2015-02-25 |
| HK1202817A1 (en) | 2015-10-09 |
| CA2869010A1 (en) | 2013-10-24 |
| CN104244978A (en) | 2014-12-24 |
| JP6446355B2 (en) | 2018-12-26 |
| EP3536342A1 (en) | 2019-09-11 |
| JP2015516975A (en) | 2015-06-18 |
| ZA201406194B (en) | 2016-08-31 |
| BR112014025339A2 (en) | 2013-10-24 |
| MX2014012285A (en) | 2015-04-13 |
| AU2018200265B2 (en) | 2019-07-18 |
| AU2013249577A1 (en) | 2014-10-02 |
| WO2013158516A1 (en) | 2013-10-24 |
| KR20150008383A (en) | 2015-01-22 |
| AU2018200265A1 (en) | 2018-02-01 |
| JP2018048169A (en) | 2018-03-29 |
| NZ631105A (en) | 2016-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201406194B (en) | Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor | |
| IL272474A (en) | Multisubstituted aromatic compounds as serine protease inhibitors | |
| IL252446A0 (en) | Hepatitis C virus inhibitors | |
| HUE049154T2 (en) | Preparations for inhibiting MASP-2-dependent complement activation | |
| ZA201306720B (en) | Hepatitis c virus inhibitors | |
| GB201213087D0 (en) | Inhibition of HIV-1 infection | |
| IL229270B (en) | Hepatitis c virus inhibitors | |
| EP2768517A4 (en) | Hepatitis c virus inhibitors | |
| SG11201500439RA (en) | Vaccine compositions for prevention against dengue virus infection | |
| ZA201309356B (en) | Hepatitis c virus inhibitors | |
| ZA201503458B (en) | Hepatitis c virus inhibitors | |
| EP2895170A4 (en) | INHIBITION OF ASTHMA TRIGGERED BY VIRAL INFECTION BY A C-KIT INHIBITOR | |
| IL233207A0 (en) | Inhibitors of sialoadhesin for the treatment of diseases caused by enveloped viruses | |
| GB201116767D0 (en) | Treatment for mitrochondrial neurogastrointestinal encephalomyopathy | |
| ZA201307019B (en) | Compositions for preventing and/or treating and infection by an hiv-1 virus | |
| ZA201308011B (en) | Processes for preparing inhibitors of the hepatitis c virus | |
| EP2712317A4 (en) | Prevention of infection | |
| PL2850075T3 (en) | Piperazine-piperidine compounds as hepatitis c virus inhibitors | |
| EP2826486A4 (en) | Agent for the treatment of hepatitis c virus | |
| AU2012905097A0 (en) | Agents and methods for inhibiting virus infection | |
| TH1201004783B (en) | Compounds that fight infection | |
| GB201217331D0 (en) | Novel compound useful for the treatment of infectious diseases |